Werfen Life Group, SA
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Werfen Life Group, SA
Medtech companies brought in $2.3 billion in financing in Q1 2017, a slight decrease from Q4 2016; device M&A deals totaled $5.8 billion, a sharp decline from the prior quarter, but there were some billion-dollar deals. Q1 diagnostics financings – totaling $1.2 billion (thanks to a $900 million Series B round by cancer diagnostics company Grail) – showed a significant increase over the preceding quarter, as did the Q1 M&As at $700 million versus the previous $87 million.
Xagenic Inc.’s Amplified Redox Assay (AuRA) POC system utilizes chip-based arrays of microelectrodes to test samples for the presence of telltale nucleic acid strands. Because it is chip-based, it should be simple to run multiple tests on a single chip, and no sample extraction or preparation is needed to run the test.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
- Accriva Diagnostics
- ITC Nexus Holding Company